Omalizumab Clinical Trials
7 recruitingDrug
Phase 24Phase 11
Showing 1–7 of 7 trials
Recruiting
Phase 1
A Study to Find a Suitable Dose of Exl-111 for Further Research
Excellergy Inc.70 enrolled1 locationNCT07356713
Recruiting
ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
Chronic Spontaneous Urticaria (CSU)Allergic Asthma
Celltrion HealthCare France225 enrolled1 locationNCT07425639
Recruiting
Phase 2
Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
Allergic Asthma
Longbio Pharma200 enrolled1 locationNCT07342803
Recruiting
Phase 2
Omalizumab Before Onset of Exacerbations
Asthma in ChildrenAtopyViral Upper Respiratory Infection
Children's National Research Institute300 enrolled1 locationNCT05332067
Recruiting
Phase 2
Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels
Food Hypersensitivity
Johns Hopkins University32 enrolled1 locationNCT06934200
Recruiting
Phase 2
Trial of JYB1904 in Chronic Spontaneous Urticaria.
Chronic Spontaneous Urticaria
Jemincare135 enrolled1 locationNCT06509334
Recruiting
Real-life Evaluation of the Efficacy of Biologicals in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
Chronic Rhinosinusitis (CRS)Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Universitaire Ziekenhuizen KU Leuven300 enrolled8 locationsNCT06683261